The United States represents a significant share of the Adefovir Dipivoxil Market, supported by the growing focus on the diagnosis and management of chronic hepatitis B. Rising awareness of liver health, increased screening among high-risk populations, and widespread availability of antiviral therapies are driving market demand. Strong healthcare infrastructure, favorable reimbursement...

The US Drug Repurposing Market is experiencing steady growth, driven by the country's strong pharmaceutical and biotechnology ecosystem, substantial research and development investments, and supportive regulatory environment. Drug repurposing has emerged as an effective strategy for accelerating the development of therapies by identifying new clinical applications for approved or...